Episode 52: Clinical Conversations: STEP, The First of Many Steps Toward the Future of Obesity Pharmacotherapy

January 31, 2022 00:24:44
Episode 52: Clinical Conversations: STEP, The First of Many Steps Toward the Future of Obesity Pharmacotherapy
Obesity: A Disease
Episode 52: Clinical Conversations: STEP, The First of Many Steps Toward the Future of Obesity Pharmacotherapy

Jan 31 2022 | 00:24:44

/

Show Notes

In this episode, obesity medicine specialist and OMA clinical education director Dr. Nicholas Pennings interviews Dr. Robert Kushner, highlighted speaker from the Overcoming Obesity 2021 Conference, about The Semaglutide Treatment Effect in People with Obesity (STEP) Trials. Topics covered include the results of the four STEP trails, obstacles to treating obesity, new obesity treatments in the pipeline, and the opportunities for increasing obesity education for future clinicians.

You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.

Episode Guest

Nicholas Pennings, DO, FOMA, Dipl. ABOM

Robert Kushner, MD

Resources Mentioned

2021 Fall Obesity Summit

Other Episodes

Episode 0

May 10, 2022 00:19:47
Episode Cover

Episode 64: Article Reviews: Clinical Practice Statements for the Management of Obesity; Part 3 of 3: Caloric Quality, Quantity and Physical Activity in Obesity Management

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews OMA Vice President Lydia Alexander,...

Listen

Episode 0

September 09, 2022 00:18:47
Episode Cover

Episode 71: Article Reviews: Clinical Practice Statements for the Management of Obesity - Cancer and Obesity; Part 2 of 2

OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association...

Listen

Episode 0

May 17, 2023 00:16:27
Episode Cover

Episode 83: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 3 of 3

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts...

Listen